Author

Mei-Ju May Chen

German Cancer Research CenterORCID 0000-0002-8721-0304Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Christoph PlassiD· 3 shared Maria Llamazares PradaiD· 3 shared Alexander Schramm· 2 shared Barbara M. GrüneriD· 2 shared Etienne SollieriD· 2 shared Kathleen Schlüter· 2 shared Madeleine DorschiD· 2 shared Michael SchereriD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Christoph PlassORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 8, 2026

Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer

Madeleine Dorsch, Felix E.G. Beaudry, Anna K. Baginska…·Barbara M. Grüner

This study identifies LOY as a driver of aggressive PDAC through epigenetic reprogramming, linking it to EMT and metastasis, and highlights its clinical relevance as a biomarker.

DOI 10.64898/2026.10.06.756936

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 5, 2026

Loss of the Y chromosome drives epigenetic and transcriptomic plasticity in lung adenocarcinoma

Kathleen Schlüter, Mei-Ju May Chen, Gizem Altun…·Maria Llamazares Prada

This study shows that loss of the Y chromosome in lung adenocarcinoma causes epigenetic and transcriptomic changes that increase lineage plasticity and poor clinical outcomes.

DOI 10.64898/2026.06.02.729627

humanDNA methylation

𝕏 PostBluesky

Cancer BiologyBlood Cancer DiscoveryPeer-reviewedMar 31, 2025

Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q

Etienne Sollier, Anna Riedel, Umut H. Toprak…·Christoph Plass

Pyjacker detects enhancer hijacking in AML, identifying MNX1 activation via 7q deletion as a novel oncogenic mechanism.

8 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky